Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
Working Capital/Sales

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Working Capital/Sales(x) 1.421.241.251.151.25

What is the latest Working Capital/Sales ratio of NATCO PHARMA ?

The latest Working Capital/Sales ratio of NATCO PHARMA is 1.42 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar20241.42
Mar20231.24
Mar20221.25
Mar20211.15
Mar20201.25

How is Working Capital/Sales of NATCO PHARMA Trending?

Years Working Capital/Sales % Change
Mar2024 1.42
14.52
Mar2023 1.24
-0.80
Mar2022 1.25
8.70
Mar2021 1.15
-8.00
Mar2020 1.25 -

Other Financial Ratios of NATCO PHARMA


Compare Working Capital/Sales ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹13,813.1 Cr -4.4% -6.2% -22.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,188.0 Cr -1.5% 4.6% 3% Stock Analytics
DIVIS LABORATORIES ₹143,074.0 Cr -4.8% -3.2% 40.7% Stock Analytics
CIPLA ₹115,768.0 Cr -1.3% -1.9% -5.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,809.0 Cr 1.1% 6.1% 27.1% Stock Analytics
DR REDDYS LABORATORIES ₹92,503.5 Cr -3.6% -2.7% -11.4% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-4.4%

-6.2%

-22.9%

SENSEX

-2.4%

0.7%

0.5%


You may also like the below Video Courses